PL435352A1 - Formulation of freeze-dried eggs of Helix aspersa aspersa snails and an aqueous extract of this preparation, as well as method of their preparation and application - Google Patents
Formulation of freeze-dried eggs of Helix aspersa aspersa snails and an aqueous extract of this preparation, as well as method of their preparation and applicationInfo
- Publication number
- PL435352A1 PL435352A1 PL435352A PL43535220A PL435352A1 PL 435352 A1 PL435352 A1 PL 435352A1 PL 435352 A PL435352 A PL 435352A PL 43535220 A PL43535220 A PL 43535220A PL 435352 A1 PL435352 A1 PL 435352A1
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- aspersa
- aqueous extract
- freeze
- snails
- Prior art date
Links
- 239000006286 aqueous extract Substances 0.000 title abstract 3
- 241001383269 Helix aspersa aspersa Species 0.000 title abstract 2
- 235000013601 eggs Nutrition 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 206010009944 Colon cancer Diseases 0.000 abstract 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 abstract 1
- 230000001093 anti-cancer Effects 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 229930014626 natural product Natural products 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem wynalazku jest preparat z liofilizowanych jaj ślimaków H. aspersa aspersa i jego wodny ekstrakt jako ważne źródła naturalnych związków wykazujących działanie przeciwnowotworowe, zwłaszcza w terapiach kombinowanych. Przedmiotem wynalazku jest również sposób otrzymywania preparatu i jego wodnego ekstraktu oraz ich terapeutyczne zastosowanie w leczeniu nowotworu jelita grubego.The subject of the invention is the preparation of freeze-dried eggs of H. aspersa aspersa snails and its aqueous extract as important sources of natural compounds with anticancer activity, especially in combination therapies. The subject of the invention is also a method of obtaining the preparation and its aqueous extract and their therapeutic use in the treatment of colorectal cancer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL435352A PL245449B1 (en) | 2020-09-18 | 2020-09-18 | Method of obtaining a preparation and an aqueous extract from lyophilized Helix aspersa aspersa snail eggs and the use of the obtained preparation and its aqueous extract in the treatment of colon cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL435352A PL245449B1 (en) | 2020-09-18 | 2020-09-18 | Method of obtaining a preparation and an aqueous extract from lyophilized Helix aspersa aspersa snail eggs and the use of the obtained preparation and its aqueous extract in the treatment of colon cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL435352A1 true PL435352A1 (en) | 2022-03-21 |
| PL245449B1 PL245449B1 (en) | 2024-08-05 |
Family
ID=80739307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL435352A PL245449B1 (en) | 2020-09-18 | 2020-09-18 | Method of obtaining a preparation and an aqueous extract from lyophilized Helix aspersa aspersa snail eggs and the use of the obtained preparation and its aqueous extract in the treatment of colon cancer |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL245449B1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL443639A1 (en) * | 2023-01-31 | 2024-08-05 | Uniwersytet Śląski W Katowicach | Condensate from Cornu aspersum snail eggs, method of its production and use, and a cosmetic composition based on condensate from Cornu aspersum snail eggs |
-
2020
- 2020-09-18 PL PL435352A patent/PL245449B1/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL443639A1 (en) * | 2023-01-31 | 2024-08-05 | Uniwersytet Śląski W Katowicach | Condensate from Cornu aspersum snail eggs, method of its production and use, and a cosmetic composition based on condensate from Cornu aspersum snail eggs |
Also Published As
| Publication number | Publication date |
|---|---|
| PL245449B1 (en) | 2024-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125772T1 (en) | MACROCYCLIC COMPOUNDS FOR THE THERAPEUTIC TREATMENT OF DISEASES | |
| CO2023004252A2 (en) | Anti-ceacam5 antibodies and conjugates and uses thereof | |
| JOP20230123A1 (en) | Combination of modified antibody drug conjugates and methods of their use | |
| PH12020551043A1 (en) | Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues | |
| CO2022002573A2 (en) | Antibodies against ilt2 and their use | |
| BR112019010020A2 (en) | compounds with anti-tumor activity against cancer cells containing egfr or her2 exon mutations | |
| CL2019000277A1 (en) | Joint treatment against cancer. | |
| CY1123666T1 (en) | MEDICINAL COMPOUNDS | |
| MX2019001920A (en) | Rna for cancer therapy. | |
| MX2020009773A (en) | Combination therapy. | |
| WO2019197605A3 (en) | Drug combinations for use in the treatment of ras-mutant cancer | |
| MX2018003331A (en) | Administration of deuterated cftr potentiators. | |
| MX2020012799A (en) | COMPOSITION AND METHOD TO TREAT CANCER ASSOCIATED WITH EGFR MUTATION. | |
| ZA201907225B (en) | Treatment of her2 positive cancers | |
| NO20071426L (en) | Cancer combination therapy including AZD2171 and Imatinib | |
| MX2020009861A (en) | Antibodies against mica and/or micb and uses thereof. | |
| AR075982A1 (en) | COMBINATION THERAPY OF A AFUCOSILATED ANTIBODY AND ONE OR MORE OF THE SELECTED CYTOKINS OF GM-CSF HUMAN, M-CSF HUMAN AND / OR IL-3 HUMAN AND COMPOSITION | |
| MX2021015974A (en) | CONJUGATES OF ANTIBODIES AND ANTI-TISULAR FACTOR DRUGS AND RELATED METHODS. | |
| BR112015033053A2 (en) | cancer treatment method in a subject, method of stimulating the immune system in a subject, method of increasing the distribution of an anticancer agent to a tumor cell, composition, and kit | |
| EA202191165A1 (en) | ELACESTRANT IN COMBINATION WITH ABEMACYCLIBUS IN WOMEN WITH BREAST CANCER | |
| MX2019006331A (en) | Methods of treating cancer using anti-pd-l1 antibodies and antiandrogens. | |
| CY1122923T1 (en) | 3-((HETERO-)ARYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES | |
| BR112021025699A2 (en) | Anti-mesothelin antibodies and immunoconjugates thereof | |
| EA201792294A1 (en) | COMBINED TREATMENT (OPTIONS) WITH THE USE OF SERIBANTUMAB | |
| EA202092518A1 (en) | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER |